Cleared Special

K222643 - Sirius Pintuition Seed, Sirius Pintuition Probe, Sirius Pintuition Base Unit (FDA 510(k) Clearance)

Oct 2022
Decision
48d
Days
Class 2
Risk

K222643 is an FDA 510(k) clearance for the Sirius Pintuition Seed, Sirius Pintuition Probe, Sirius Pintuition Base Unit. This device is classified as a Temporary Tissue Marker (Class II - Special Controls, product code PBY).

Submitted by Sirius Medical Systems B.V. (Eindhoven, NL). The FDA issued a Cleared decision on October 19, 2022, 48 days after receiving the submission on September 1, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4300. To Temporarily (< 30 Days) Mark A Tissue Site Intended For Surgical Removal. The Tissue Marker Is Surgically Removed With The Target Tissue..

Submission Details

510(k) Number K222643 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 01, 2022
Decision Date October 19, 2022
Days to Decision 48 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code PBY - Temporary Tissue Marker
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4300
Definition To Temporarily (< 30 Days) Mark A Tissue Site Intended For Surgical Removal. The Tissue Marker Is Surgically Removed With The Target Tissue.